The first case of Philadelphia chromosome-negative acute promyelocytic leukemia following imatinib for chronic myelogenous leukemia.
Abstract
In chronic myelogenous leukemia, chromosomal abnormalities in Philadelphia-negative cells are rare and usually transient, but can infrequently lead to myelodysplastic syndrome and/or acute myeloid leukemia. We report an 82-ear-old patient with an 11-year history of chronic myelogenous leukemia, in complete cytogenetic response, who developed Philadelphia-negative t(15;17)/PMLRARA acute promyelocytic leukemia. This isolated case reaffirms several important clinicopathologic and biologic aspects of chronic myelogenous leukemia, and sheds a unique light on its Philadelphia-negative hematopoiesis. It also underlines the importance of continued cytogenetic monitoring of patients in complete cytogenetic response for the emergence of new chromosomal abnormalities.
Links
Authors
Wakim JJ, Tirado CA, Dowell J, Chen W
Institution
Division of Hematology and Oncology, University of Texas Southwestern Medical Center, Dallas, TX, USA. jad.wakim@phhs.org
Source
Cancer genetics 205:3 2012 Mar pg 124-7MeSH
Aged, 80 and overAntineoplastic Agents
Chromosome Aberrations
Humans
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
Leukemia, Promyelocytic, Acute
Male
Piperazines
Pyrimidines
Remission Induction
Translocation, Genetic
Pub Type(s)
Case ReportsJournal Article
Language
eng
PubMed ID
22469511
Log In

